CoChat

New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment

Open access
Li, Mengshuang, Xin, Meng, Guo, Chuanlong, Lin, Guiming, Wu, Xianggen · 2017 · Drug Development and Industrial Pharmacy

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

CONTEXT: A stable topical ophthalmic curcumin formulation with high solubility, stability, and efficacy is needed for pharmaceutical use in clinics. OBJECTIVES: The objective of this article was to describe a novel curcumin containing a nanomicelle formulation using a polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol (PVCL-PVA-PEG) graft copolymer. METHODS: Nanomicelle curcumin was formulated and optimized and then further evaluated for in vitro cytotoxicity/in vivo ocular irritation, in vitro cellular uptake/in vivo corneal permeation, and in vitro antioxidant activity/in vivo anti-inflammatory efficacy. RESULTS: The solubility, chemical stability, and antioxidant activity were greatly improved after the encapsulation of the PVCL-PVA-PEG nanomicelles. The nanomicelle curcumin ophthalmic solution was simple to prepare and the nanomicelles are stable to the storage conditions, and it had good cellular tolerance. Nanomicelle curcumin also had excellent ocular tolerance in rabbits. The use of nanomicelles significantly improved in vitro cellular uptake and in vivo corneal permeation as well as improved anti-inflammatory efficacy when compared with a free curcumin solution. CONCLUSIONS: These findings indicate that nanomicelles could be promising topical delivery systems for the ocular administration of curcumin.

Overview

Integrity signals

Registry

Crossref · 10.1080/03639045.2017.1349787

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 4

  1. Lou J, 2014, Int J Nanomed, 9, 2517
  2. 10.1002/wnan.1272 · DOI · Paper page
  3. Tonnesen HH., 2002, Die Pharmazie, 57, 820
  4. Jahanshiri Z, 2012, Iran J Public Health, 41, 72

Cited by

See all 103

Metadata

Authors
Li, M., Xin, M., Guo, C., Lin, G., & Wu, X.
Affiliations
  • Qingdao University of Science and Technology (CN)
  • Binzhou Medical University (CN)
  • Chinese Academy of Sciences (CN)
Corresponding author
Wu, Xianggen
Venue
Drug Development and Industrial Pharmacy
Published
2017-07-11
Volume
43
Issue
11
Pages
1846-1857
ISSN
  • 0363-9045 (ISSN-L)
  • 1520-5762
OpenAlex
W2733089885
Cited by
103
References
41
Citations by year
2026: 5 · 2025: 14 · 2024: 10 · 2023: 15 · 2022: 17 · 2021: 10 · 2020: 13 · 2019: 11 · 2018: 6 · 2017: 2
FWCI
4.51
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Drug Development and Industrial Pharmacy (publishedVersion)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
  • Figshare (cc-by)
Funders
  • National Natural Science Foundation of China (81271036, 81500751)
  • Natural Science Foundation of Shandong Province, China (ZR2015PH062)
  • Shandong Province (2015GSF118121)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
curcumin, nanomicelles, ocular drug delivery, ophthalmic preparations, corneal permeation, eye irritation, antioxidant activity, anti-inflammatory efficacy, curcumin solubility, curcumin stability, cellular uptake
MeSH terms
Animals, Anti-Inflammatory Agents, Chemistry, Pharmaceutical, Cornea, Curcumin, Micelles, Ophthalmic Solutions, Polyethylene Glycols, Polyvinyls, Rabbits, Solubility, Drug Delivery Systems, Nanoparticles, Administration, Ophthalmic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment. https://app.cochat.ai/papers/10.1080/03639045.2017.1349787
The paper
Li, M., Xin, M., Guo, C., Lin, G., & Wu, X. (2017). New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment. Drug Development and Industrial Pharmacy. https://doi.org/10.1080/03639045.2017.1349787

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.